Serine encodes drug selectivity in human OAT1

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Organic anion transporting polypeptide 1 (OAT1) is a key transporter in drug disposition.
• Species-specific differences in OAT1 affinity affect drug efficacy and safety.
• Understanding these differences is crucial for drug development.

Purpose of the Study:

• To elucidate the structural basis for the higher affinity of human OAT1 compared to rat OAT1 for certain drugs.
• To identify key residues and interactions responsible for high-affinity drug binding.

Main Methods:

• Comparative structural analysis of human and rat OAT1.
• Site-directed mutagenesis to investigate the role of specific residues.
• Ligand binding assays to assess drug affinity.

Main Results:

• Human OAT1 possesses a unique serine 203 residue not found in rat OAT1.
• Serine 203 coordinates with a chloride ion, forming a critical interaction site.
• This S203-chloride interaction is essential for the high-affinity binding of olmesartan and other OAT1 substrates.

Conclusions:

• The S203-chloride interaction in human OAT1 is a key determinant of high-affinity drug binding.
• This finding provides structural insights into species-specific drug transport.
• The results have implications for predicting drug interactions and optimizing drug design.